Layered Peptide Arrays-high Throughput Screening Read more about Layered Peptide Arrays-high Throughput Screening US Application 60/811,240Filed on 2006-06-05
Prevention Of Tissue Ischemia Read more about Prevention Of Tissue Ischemia US Application 60/864,153Filed on 2006-11-02
Novel Insertion Sites In Pox Vectors Read more about Novel Insertion Sites In Pox Vectors US Application 60/448,591Filed on 2003-02-20
Macrocyclic Grb2 SH2 Domain-binding Inhibitors Prepared Using Achiral Alkenyl Amines Read more about Macrocyclic Grb2 SH2 Domain-binding Inhibitors Prepared Using Achiral Alkenyl Amines US Application 60/867,307Filed on 2006-11-27
ENGINEERED ANTIBODY CONSTANT DOMAIN MOLECULES Read more about ENGINEERED ANTIBODY CONSTANT DOMAIN MOLECULES US Application 61/063,245Filed on 2008-01-31
Identification Of A Dominant B Cell Epitope From NY-ESO-1: Implications For Antibody Detection Against Tumor-associated Antigens Read more about Identification Of A Dominant B Cell Epitope From NY-ESO-1: Implications For Antibody Detection Against Tumor-associated Antigens US Application 60/572,474Filed on 2004-05-20
Peptide And Peptidomimetic Inhibitors Of Smoothened Protein As Anti-neoplastic Agents Read more about Peptide And Peptidomimetic Inhibitors Of Smoothened Protein As Anti-neoplastic Agents US Application 60/855,422Filed on 2006-10-31
Aviden-Rhpdaminex (AV-3ROX) As A Self-Quenching Fluorophore Useful In Imaging Technology Read more about Aviden-Rhpdaminex (AV-3ROX) As A Self-Quenching Fluorophore Useful In Imaging Technology US Application 60/922,801Filed on 2007-04-10
CKAP4/p63 Is A Bladder Epithelial Cell Bladder Cell Receptor For The Antiproliferative Factor (APF) From Interstitial Cystitis Patients Read more about CKAP4/p63 Is A Bladder Epithelial Cell Bladder Cell Receptor For The Antiproliferative Factor (APF) From Interstitial Cystitis Patients US Application 60/833,828Filed on 2006-07-27
Methods And Compositions For Assessing Alterations In Gene Expression Patterns In Clinically Normal Tissues Obtained From Heterozygous Carriers Of Mutant Genes Associated With Cancer And Methods Of Use Thereof Read more about Methods And Compositions For Assessing Alterations In Gene Expression Patterns In Clinically Normal Tissues Obtained From Heterozygous Carriers Of Mutant Genes Associated With Cancer And Methods Of Use Thereof US Application 60/840,842Filed on 2006-08-29